Skip to Content

  • Search

View Additional Section Content

RTOG 1205 – Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation versus Bevacizumab Alone as Treatment for Recurrecnt Glioblastoma.

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01730950?term=rtog+1205&rank=1

Clinical Trial Categories

  • Brain Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details